Stroke is a major cause of disability and cognitive impairment, accounting for 5.2% deaths worldwide. Antiplatelets and anticoagulants have been widely used as prevention of recurrent stroke. Recently, lumbrokinase has been used in stroke and other cardiovascular patients, but further research is needed.
CITATION STYLE
Mardiono, M. M. L. (2024). Peran Lumbrokinase pada Tata Laksana Stroke Iskemik. Cermin Dunia Kedokteran, 51(2), 95–98. https://doi.org/10.55175/cdk.v51i2.1021
Mendeley helps you to discover research relevant for your work.